Expert Consensus on Nutrition Standards for Intensive Care Units in Resource Limited Settings
International Consensus on Nutritional Practices in Resource-Limited Intensive Care Units: The RES-Q Nutri ICU (REsource-limited Standards & Quality for Nutrition in the ICU) Modified Delphi Consensus Study
The goal of this observational study is to develop practical, expert-agreed standards for nutrition care of critically ill adults in intensive care units (ICUs) in resource-limited settings. The main question it aims to answer is:
Which nutrition practices do international ICU experts agree are essential and achievable for critically ill patients in hospitals with limited resources?
Participants will be ICU doctors, dietitians and nurses with experience of nutrition care in resource-limited settings. They will rate a set of statements across five areas of ICU nutrition in anonymous online survey rounds. After each round they will see a summary of the group's responses and may revise their ratings. A statement reaches agreement when at least 80% of experts agree with it, and rounds will continue until responses stabilise. ICU survivors and family members will also review a plain-language version of the statements, and their feedback will be shared with the expert panel.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Background: International ICU nutrition guidelines come almost entirely from trials in high-income settings. Lower-middle-income countries contributed less than 1% of patients and low-income countries none. ICUs that lack dietitians, feeding pumps, indirect calorimetry, post-pyloric access, specialised formulas or laboratory monitoring have no agreed minimum standard. This includes ICUs in low- and middle-income countries, remote or public facilities anywhere, and ICUs during surges. "Resource-limited" here is defined by what resources are available, not by World Bank income group.
Design: This is an international, web-based modified Delphi study reported according to ACCORD. A multidisciplinary Steering Committee drafts and refines the statements and analyses responses but does not vote. An independent Delphi methodologist oversees the process to limit bias. Panellists are recruited by purposive sampling through professional networks and societies, aiming for diversity in profession, geography, sex and resource setting.
Statement development: Round 1 statements come from a systematic search of PubMed, Embase, Scopus, Web of Science, Google Scholar and ESPEN, ASPEN and ESICM guidelines, covering adult literature in English from 2015 to 2026. Two reviewers screen in Rayyan and report selection in a PRISMA diagram. Statements are grouped into five domains: screening and assessment; timing, route and delivery; monitoring and metabolic control; micronutrients and special situations; and team, documentation and quality improvement. An evidence summary goes out with Round 1.
Delphi process: Panellists will rate statements on a 9-point scale, give free-text comments and describe the resource limitations in their practice. In later rounds they receive their own previous rating, the group median and IQR, percentage agreement and anonymised comments. A statement is revised when at least 10% of respondents (at least four) raise the same issue, and revisions that change its meaning are re-rated. Rounds continue until responses are stable, and the panel then approves the final set.
Patient involvement: Five to ten ICU survivors or patient representatives take part in single interviews in their preferred language and rate the value of the Round 1 statements. Their views are fed back to the panel but do not count towards consensus.
Analysis: Consensus to include is at least 80% of ratings at 7-9, and consensus to exclude is at least 80% at 1-3. Stability is tested with the Wilcoxon signed-rank test between consecutive rounds. If attrition exceeds 20%, a sensitivity analysis is run. Exploratory comparisons are made by profession and by income setting.
Ethics: Approved by the Institutional Ethics Committee, Father Muller Medical College (FMIEC/CCM/495/2026), with electronic consent from panellists.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Vijay Sundarsingh, MD, DM
- Phone Number: +918072952625
- Email: vijayss87pm@gmail.com
Study Locations
-
-
Karnataka
-
Mangalore, Karnataka, India, 575002
- Father Muller Medical College
-
Contact:
- Vijay Sundarsingh, MD,DM
- Phone Number: +918072952625
- Email: vijayss87pm@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The study population is an international, multidisciplinary panel of about 40 to 50 professionals with expertise in adult critical care nutrition practice, research, education or guideline development. It includes intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers and allied professionals involved in ICU nutrition. At least 60% of the panel will be from low- and middle-income countries or will have current experience of working in resource-limited ICUs, and at least one-third will be non-physicians. In addition, 5 to 10 adult ICU survivors or patient-care representatives, mainly from resource-limited settings, will take part in patient and public involvement interviews.
Description
Inclusion Criteria:
-
Panellists will be eligible if they meet all of the following criteria:
-
Professional background: Adult ICU clinicians or researchers involved in critical care nutrition practice, research, education, or guideline development, and belonging to one of the following professional groups: intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers, or allied professionals involved in ICU nutrition.
-
Relevant expertise: At least one of the following:
- At least one peer-reviewed publication related to critical care nutrition.
- A minimum of 10 years of relevant ICU or nutrition experience, with at least 50% of clinical time spent managing critically ill patients.
- Involvement in nutrition guideline or protocol development.
- A leadership or advocacy role in a critical care or nutrition society; or
- At least 5 years of direct experience working in resource-limited ICU settings.
-
Willingness to participate: Willingness to participate in multiple Delphi rounds.
-
Professional diversity: At least one-third of the final panel will comprise non-physicians.
-
Exclusion Criteria:
- 1. Failure to provide implied consent through survey participation. 2. Inability to comprehend or independently vote on statements written in English. (To support non-native English speakers, all Delphi statements will be written in clear, unambiguous English.) 3. Incomplete Round 1 response with no rating data.
Study Plan
How is the study designed?
Design Details
- Observational Models: OTHER
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Expert Delphi Panel
International multidisciplinary panel of approximately 40 to 50 experts in adult critical care nutrition, including intensivists, ICU dietitians, critical care nurses, clinical pharmacists and nutrition researchers.At least 60% will be from low- and middle-income countries or resource-limited ICUs, and at least one-third will be non-physicians. Panellists will rate draft statements on minimum nutrition standards over iterative anonymous online rounds until consensus and stability are reached. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To establish consensus-based minimum standards for assessment, initiation, delivery, and monitoring of nutritional therapy in resource-limited ICUs.
Time Frame: Through study completion, an average of 18 months
|
Number and proportion of Delphi statements reaching consensus to include (at least 80% of panellists rating 7 to 9 on a 9-point Likert scale) or consensus to exclude (at least 80% rating 1 to 3), with response stability between consecutive rounds (no significant variation on the Wilcoxon signed-rank or Kruskal-Wallis test, p of 0.05 or more). For each statement, the median, interquartile range and percentage agreement will be reported. |
Through study completion, an average of 18 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To identify pragmatic adaptations of existing international ICU nutrition guidelines for resource-limited settings.
Time Frame: Through study completion, an average of 18 months
|
Number and proportion of statements describing adaptations of ESPEN, ASPEN or ESICM recommendations that reach consensus to include (at least 80% rating 7 to 9) with response stability. |
Through study completion, an average of 18 months
|
|
To identify essential (minimum) nutritional practices for critically ill patients in ICUs
Time Frame: Through study completion, an average of 18 months
|
Number and proportion of statements rated "essential" (7 to 9) by at least 80% of panellists with response stability, reported for each of the five domains. |
Through study completion, an average of 18 months
|
|
To identify research priorities in ICU nutrition for resource-limited settings.
Time Frame: Through study completion, an average of 18 months
|
Research priorities identified from statements reaching no consensus after repeated rating, and from themes in panellists' free-text comments, analysed thematically. |
Through study completion, an average of 18 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Vijay Sundarsingh, MD,DM, Father Muller Medical College
- Principal Investigator: Soumaya Touzani, MD, PhD, Hassan II University Hospital
- Principal Investigator: Prashant Nasa, MD,FNB, University Hospital Plymouth NHS Trust, Plymouth, UK
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FMIEC/CCM/495/2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data will not be shared. Participants consented to their responses being reported only in aggregate, and the small expert panel carries a risk of re-identification. Aggregate results for each statement will be published in the final manuscript.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.